ESC Premium Access

Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction

Congress Session

About the speaker

Doctor Masato Kawasaki

Osaka General Medical Center, Osaka (Japan)
0 follower

8 more presentations in this session

Prediction of ventricular tachyarrhythmias occurrence by changes in physiological parameters derived from implantable-cardioverter defibrillators

Speaker: Doctor N. Chan (Hong Kong, CN)

Thumbnail

An evaluation of the effect of the subcutaneous implantable defibrillator smartpass filter on inappropriate shock reduction.

Speaker: Doctor T. Brouwer (Amsterdam, NL)

Thumbnail

The effectiveness of the wearable cardioverter defibrillator in a real world environment

Speaker: Doctor C. Abrahim (Springfield, US)

Thumbnail

Sudden cardiac arrest in patients with cardiac implantable electronic devices

Speaker: Doctor A. Sharifzadehgan (Paris, FR)

Thumbnail

Implantable cardioverter-defibrillator therapy in patients presenting with acute coronary syndromes - useful before 40 days?

Speaker: Doctor J. Ferreira (Coimbra, PT)

Thumbnail

Access the full session

Poster Session 1 - Device treatment of ventricular arrhythmias and sudden cardiac death

Speakers: Doctor M. Kawasaki, Doctor N. Chan, Doctor T. Brouwer, Doctor C. Abrahim, Doctor A. Sharifzadehgan...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk